Cargando…
Representation of Investigators by Gender Among Authors of Phase 3 Oncology Trials Worldwide
This cross-sectional study uses worldwide oncology trial data to examine the proportion of female investigators in each country and across all trials.
Autores principales: | Muquith, Maishara, Pham, Tri, Espinoza, Magdalena, Hsiehchen, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881765/ https://www.ncbi.nlm.nih.gov/pubmed/35212754 http://dx.doi.org/10.1001/jamanetworkopen.2022.0031 |
Ejemplares similares
-
Treatment Beyond Progression After Anti-PD-1 Blockade in Hepatocellular Carcinoma
por: Lim, Mir, et al.
Publicado: (2023) -
Deficiencies in the Designs and Interventions of COVID-19 Clinical Trials
por: Hsiehchen, David, et al.
Publicado: (2020) -
Prevalence of Female Authors in Case Reports Published in the Medical Literature
por: Hsiehchen, David, et al.
Publicado: (2019) -
The Cooperative Landscape of Multinational Clinical Trials
por: Hsiehchen, David, et al.
Publicado: (2015) -
Representation of Women Authors in Trials of Lipid‐Lowering Therapy
por: Raghu Subramanian, Charumathi, et al.
Publicado: (2021)